Issuu

Mount Sinai Center for Transgender Medicine and Surgery Annual Report 2025

Mission The Center for Transgender Medicine and Surgery’s mission is to provide seamless patient-centered care for transgender and gender diverse people and their families across the lifespan and to be global leaders in advancing transgender healthcare, research and education.

Vision Expert Care Pioneering Research World-Class Education

About Us The Mount Sinai Center for Transgender Medicine and Surgery (CTMS) delivers advanced care for transgender and gender diverse people. We provide caring, compassionate services to meet your individual needs—including medical care, gender-affirming surgeries, behavioral health services, and other support services.

Expert Care Pioneering Research World-Class Education

Dear Friends and Colleagues, The 2025 Annual Report of Mount Sinai Health System’s Center for Transgender Medicine and Surgery (CTMS) showcases our continued significant growth. As you will read, we have managed another year of major accomplishments in the care of our transgender and gender-diverse patients. Our 2025 Annual Report highlights progress in continuing to meet the needs of the people we serve. Our expanding program now sits in multiple locations throughout the Mount Sinai Health System. We remain the leading comprehensive transgender medical program in the country, at the forefront of advanced medicine, treatment, and clinical education services, as well as research. In 2025, the number of patients treated and the number of scholarly works disseminated were both the highest yet. Even as we navigate new challenges to address, we should reflect on the year’s huge successes in transgender health care. On behalf of the Center for Transgender Medicine and Surgery, we thank our patients, staff, and supporters for taking this journey in 2025, anticipating energy to continue to advance care going forward into 2026.

CTMS Network Joshua D. Safer, MD, FACP, FACE Executive Director, Mount Sinai Center for Transgender Medicine and Surgery (he/him)

Bella Avanessian, MD

Aaron Grotas, MD

Plastic Surgeon, Mount Sinai Center for Transgender Medicine and Surgery (she/her)

Urologist, Mount SinaiUnion Square (he/him)

Marci Bowers, MD Elan Horesh, MD

Antonio E. Urbina, MD Medical Director, Mount Sinai Institute for Advanced Medicine and Comprehensive Health Program (he/him)

Plastic Surgeon, Mount Sinai Center for Transgender Medicine and Surgery (he/him)

Zoe Rodriguez, MD Ann Tran, MD

Eric Kutscher, MD Primary Care Lead, Mount Sinai Center for Transgender Medicine and Surgery (he/him)

GYN Surgeon, Mount Sinai Center for Transgender Medicine and Surgery (she/her)

Endocrinologist, Mount Sinai DoctorsWest 23rd Street (he/him)

OBGYN, Mount SinaiUnion Square (she/her)

Mark Courey, MD Yasmina Zoghbi, MD

Cesar Abuchaibe, MD

OBGYN Surgeon, Mount Sinai Center for Transgender Medicine and Surgery (she/her)

Plastic Surgeon, Mount Sinai Center for Transgender Medicine and Surgery (she/her)

Otolaryngologist, Mount Sinai Doctors5 East 98th Street (he/him)

Joshua Rosenberg, MD

Max Lichtenstein, MD

Peter W. Henderson, MD, MBA, FACS

Director, Psychiatry, Mount Sinai Center for Transgender Medicine and Surgery (he/him)

Plastic Surgeon, Mount Sinai Center for Transgender Medicine and Surgery (he/him)

Ralph Fader, MD

Miroslav Djordjevic, MD, PhD

Psychiatrist, Mount Sinai Center for Transgender Medicine and Surgery (he/him)

Urologist, Mount Sinai Doctors445 East 77th Street, Urology (he/him)

Facial Plastic Surgeon, Mount Sinai DoctorsEast 85th Street (he/him)

Mabel Yau, MD

Jess Ting, MD Plastic Surgeon, Mount Sinai Center for Transgender Medicine and Surgery (he/him)

Pediatric Endocrinologist, The Mount Sinai Hospital (she/her)

Rajveer Purohit, MD, MPH

Sangyoon Jason Shin, DO

Urologist, Mount Sinai Doctors445 East 77th Street, Urology (he/him)

Medical Director, Inpatient Services, Mount SinaiUnion Square (he/him)

CTMS Network Jiby Yohannan, MD

Jean-Carlo Rodriguez, MD

Andrew Para, MD

Endocrinologist and Assistant Professor, Mount Sinai Health System (he/him)

Medical Provider and Assistant Professor, Mount Sinai Health System (he/him)

Dermatologist, Mount Sinai-Union Square (he/him)

Daniel Slack, MD

Andrew Goodman, MD

Endocrinologist and Assistant Professor, Mount Sinai Health System (he/him)

Medical Director, Mount Sinai Doctors-52 West Eighth Street Assistant Professor, Family Medicine (he/him)

John Henry Pang, MD Adjunct Clinical Assistant Professor, Mount Sinai Health System (he/him)

Joan Villacasio, NP Nurse Practitioner, Mount Sinai Health System (she/her)

Anita Venkatesan, MD Attending Physician, Department of Medicine, Mount Sinai Health System (she/her)

Center for Transgender Medicine and Surgery Clinical Services Overall patient experience: We continued to create a patient experience that is efficient, safe, and friendly from first point of contact with our team of registrars, through the entire delivery of care. Our efforts resulted in improved comments from our patients. We anticipate continuing our effort to improve patient experience as a priority in 2026. Primary Care: In 2025, we had more than 600 CTMS patients continually engaging in primary care across the Mount Sinai Health System, the most we have recorded yet. While some patients receive primary care elsewhere, we strive to create an environment where patients can find a high-quality, culturally sensitive medical home for care of all types within the Mount Sinai Health System. Endocrinology: We built on our reputation as the choice destination for endocrine care for transgender people, and by the end of the year had provided gender-affirming hormone therapy to approximately 4,800 patients. Surgical Services: Surgical services continued to expand this year. We have robust surgical services for transgender and gender-diverse patients at all four Mount Sinai inpatient hospitals in Manhattan (New York Eye and Ear Infirmary of Mount Sinai, Mount Sinai West, The Mount Sinai Hospital, and Mount Sinai Morningside) along with several Mount Sinai ambulatory locations. Inpatient care: Our completely novel interdisciplinary approach to inpatient transgender surgical care continued to earn us top scores in the Press Ganey survey. Spiritual Care: The spiritual care team at Mount Sinai plays an essential role in the interdisciplinary care of patients undergoing gender-affirming surgery through CTMS. Rooted in a trauma-informed, multifaith model, the work supports the spiritual needs and emotional well-being of our patients, especially those undergoing surgeries. The spiritual care team is much appreciated 6

by patients and has helped multiple patients navigate challenges with surgery. Education and Research: In 2025, the CTMS portfolio of fellowships included a New York Statefunded transgender medicine fellowship, an LGBTQ+ fellowship, a CTMS Plastic Surgery fellowship, a CTMS Psychiatry fellowship, and a CTMS Genitourinary (GU) fellowship. In addition, gender-affirming surgery continued as a core rotation for the Mount Sinai Plastic Surgery Residency, and gender-affirming hormone therapy continued as a core rotation for the Mount Sinai Endocrinology Fellowship program. The Mount Sinai free online course for primary care providers in transgender health care (www.coursera.org/learn/ transgender-medicine) was used by approximately 6,000 students worldwide in 2025. CTMS also had more than 20 presentations between the 2025 European Professional Association for Transgender Health conference in Germany and the United States Professional Association for Transgender Health in New Mexico. This year we also published more than 20 papers across the range of gender-affirming care. Clinical Services: In 2025, more than 4,800 transgender and gender-diverse (TGD) patients were actively receiving gender-affirming medical care with providers at the Mount Sinai Health System. In addition, more than 1,500 gender-affirming surgeries were performed, with surgeries growing across all four Mount Sinai inpatient hospitals in Manhattan, along with several ambulatory locations. The Center for Transgender Medicine and Surgery was launched in 2016 and is the most comprehensive TGD program in the country. To date, more than 17,000 TGD patients have received gender-affirming care through CTMS. CTMS medical services include primary care, endocrinology, plastic surgery, gynecology, urology, otolaryngology, and mental health services. In 2025, we hired a new program director, a financial coordinator, and an additional registrar.

Center for Transgender Medicine and Surgery Dissemination, Quality, Training, and Media

As has become usual, CTMS was a major presence at the annual conference of the World Professional Association for Transgender Health meeting. The international and regional meetings alternate years. In 2025, the United States meeting was held in New Mexico and the European meeting was held in Germany. We had more than 20 presentations between the two meetings, with a large fraction likely to result in publications over the next year or two. This year we published approximately 20 papers across the range of gender-affirming care. The Mount Sinai free online course for primary care providers in transgender health care (www. coursera. org/learn/transgender-medicine) was used by approximately 6,000 students worldwide.

Center for Transgender Medicine and Surgery Patient Feedback CTMS receives input and feedback from our patients through both formal and informal avenues. These include patient feedback surveys, patient satisfaction surveys such as Press Ganey, and informal feedback given to providers, practice managers, and office staff. The feedback provides us with a continuous process through which we can identify areas for improvement and optimization in the design, delivery, and evaluation of services. Patient feedback is reviewed

by an interdisciplinary team to identify individual-level experiences and, in aggregate, to identify significant trends. We see this as an essential process in the belief that care designed for populations with specific health concerns necessarily must include input from those populations. Beyond areas for improvement, patient feedback also gives us the ability to raise up our providers and office staff for their dedication and delivery of conscientious care to the patients they serve.

CTMS team members attend a recent WPATH meeting.

Patient Testimonials I have avoided coming to get this checkup for five years in fear of the procedure and the vulnerability during it. I felt totally at ease and the sensitivity to my particular needs that I experienced makes me more likely to be more proactive with my preventive care.

Ralph P. Fader, MD, and the doctor training under him were both absolutely so kind. It was a pleasure to meet them. They also provided me with insights regarding my future surgical plan. A+ all around.

Provider was very kind, respectful, and knowledgeable about gender issues and about the surgeries I was having. He developed a rapport with me quite easily.

The doctor was responsive and filled my forms out within a day. I’ve never had an office or a doctor work with me before like this. It’s so refreshing and appreciated.

Honestly as a transgender patient, and a patient in general, I have never ever felt as cared for as I did in the care of Emily Schmidt-Beuchat, MD. She was wonderful, took so much time with me, and explained everything thoroughly and concisely. Thank you!!

Patient Population Patients With Active Gender Affirming Hormone Prescriptions From Mount Sinai Providers

More intense coloring represents larger numbers of patients in that location.

Patient Care Statistics Surgery Volume by Surgery Type (2020–2025)

The CTMS interdisciplinary team meets to review patient care plans.

Goals for 2026

CTMS team members supporting our colleagues at Callen-Lorde.

Clinical Services • Primary Care: Expand the Mount Sinai CTMS primary care network especially to include more sites outside Manhattan for greater patient convenience. • Endocrinology: Leverage our expanded endocrinology team to increase the number of patients actively receiving gender affirming hormone therapy. • Surgery: Continue to shrink the time it takes patients to navigate the surgery evaluation process.

Research, Education, and Dissemination • Further characterize the patients seeking gender affirming health care at Mount Sinai for future dissemination. • Publish the many papers in progress that began as presentation abstracts at our national and international conferences. • Present at WPATH in November 2026 in Mexico City

Publications Publications 1.

Atwater BL, Kirkik D, Wilson SK, Koca O, Purohit RS, Muñoz Vera C, Dunglison N, Gross MS. Short-term revision rate of Rigicon Testi10 testicular prosthesis in adolescents and adults: a retrospective chart review. Int J Impot Res. 2025;37(4):303–309. doi:10.1038/s41443024-00893-8 Bizic M, Bencic M, Stojanovic B, Djordjevic ML. Neourethroplasty in masculinizing gender affirmation surgery. Int J Reconstr Urol. 2025;3(2):187-196. doi:10.4103/IJRU.IJRU_34_25 Bucca B, Purohit RS. Hair management for transgender genital surgery: a comparative review of techniques and implications for neovaginal and urethral health. Int J Reconstr Urol. 2025;3(2):197-208. doi:10.4103/IJRU. IJRU_38_25 Dickstein DR, Kapouranis T, Sigel K, Wheldon CW, Nvepu E, Javier NM, Stewart R, Galsky M, Sfakianos J, Safer JD, Stock R, Goodman K, Rosser BRS, Flynn KE, Marshall DC. Sexual health outcomes in sexual minority and heterosexual men after prostate radiation therapy. Int J Radiat Oncol Biol Phys. 2025;122(2):416–423. doi:10.1016/j.ijrobp.2025.01.023

10. Ravetch E, Krishnamurthy N, Weltz C, Safer JD. Clinical characteristics of transgender patients with breast cancer: a single institution experience. The Oncologist. 2025;30(5):oyaf087. doi:10.1093/oncolo/oyaf087 11.

Schmidt-Beuchat E. Clinical guidance and recommendations for in-office management of the neovagina: a review. Int J Reconstr Urol. 2025;3(2):149-156. doi:10.4103/IJRU.IJRU_23_25

12. Slack DJ, Krishnamurthy N, Garrity M, Chen D, Kyweluk M, Trakhtenberg E, Kirkley J, Safer JD. Choice of hormone assay to monitor feminizing gender-affirming hormone therapy. Endocr Pract. Published online September 2025. doi:10.1016/j.eprac.2025.08.010 13. Sljivich M, Torres C, Chen D, Yatsenko T, Wiklund P, Djordjevic M, Purohit RS. Feasibility and outcomes after robot‑assisted sigmoid vaginoplasty for gender dysphoria. Urology. 2025;S0090-4295(25)00574-6. doi:10.1016/j. urology.2025.06.003 14. Stojanovic B, Bencic M, Duisin D, Bizic M, Djordjevic ML. Psychosexual outcomes and quality of life after metoidioplasty in transmen. Int J Reconstr Urol. 2025;3(2):230-237. doi:10.4103/IJRU.IJRU_24_25

Ho P, Schmidt-Beuchat E, Sljivich M, Nyein E, Djordjevic M, Tran A, Purohit RS. Impact of vaginectomy technique on the outcomes of transmasculine gender affirming surgery. J Sex Med. 2025;22(8):1483-1487. doi:10.1093/ jsxmed/qdaf148

15. Tinajero JD, Oliver RL, Flint RA, Ahmed J, Rashid T, Djordjevic M, Di Taranto G. Enhancing outcomes with single-stage robotic hysterectomy and metoidioplasty: a new paradigm in gender-affirmation surgery. Int J Reconstr Urol. 2025;3(2):226-229. doi:10.4103/IJRU.IJRU_22_25

Ho P, Schmidt-Beuchat E, Sljivich M, Djordjevic M, Nyein E, Purohit RS. Testicular implant complications after transmasculine gender affirming surgery. Int Braz J Urol. 2025;51(2):e20240427. doi:10.1590/S1677-5538. IBJU.2024.0427

16. Torres C, Purohit RS. Vaginoplasty: maximizing aesthetic and functional outcomes of the vulva. Int J Reconstr Urol. 2025;3(2):238-248. doi:10.4103/IJRU.IJRU_27_25

Krishnamurthy N, Ravetch E, Karim S, Safer JD. Screening mammography utilization among transgender and gender diverse individuals: insights from a large single‐institution center. J Gen Intern Med. 2025. doi:10.1007/s11606-025-09824-9

Purohit RS. Introduction. Int J Reconstr Urol. 2025;3:129.

Ramsay A, Blankson J, Finnerty-Haggerty L, Wu J, Safer JD, Pang JH. (2025) Using a novel and validated survey tool to analyze sexual functioning following vaginoplasty in transgender individuals. Sexual Health 22, SH24070. https://doi.org/10.1071/SH24070

Presentations Presentations AUA | Las Vegas, Nevada | April 26-29, 2025 1.

Chen DM, Pai S, Shamamian P, Karim S, Sljivich M, Torres C, Montalmant K, Laarakker A, Pang JH, Avanessian B, Horesh E, Henderson P, Purohit RS, Horn S, Ting J. “The Effects of Intraoperative Methadone on Transgender and Gender-diverse Patients Receiving Vaginoplasty”. Oral presentation.

Harb O, Torres C, Wiklund P, Djordjevic M, Purohit RS. “Peritoneal Flap Versus Sigmoid Vaginoplasty For Treatment Of Vaginal Stenosis After Gender-Affirming Vaginoplasty”. Oral Presentation.

Purohit RS, Torres C, Djordjevic M. “Outcomes And Patient Satisfaction Of Abdominal Phalloplasty In Transgender Men”. Oral Presentation.

Ho P, Torres C, Purohit RS. “Changes in Urinary Storage Symptoms after Gender Affirming Vaginoplasty”. Oral Presentation.

PSRC | St. Louis, Missouri | May 1-5, 2025 1.

Janet C. Coleman‑Belin, Peter Shamamian, Ivory Fu, Subha Karim, Anya Wang, Ehud Flis, Ann Tran, Yasmina Zoghbi, John Henry Pang, Bella Avanessian, Elan Horesh, Peter J. Taub, Jess Ting. “The Relationship Between Surgical Complications and Gender Dysphoria Index After Primary Vaginoplasty: A Multiple Regression Analysis.” Oral Presentation.

Derek Chen, Sananda Pai, Peter Shamamian, Subha Karim, Michaela MD Sljivich, Camille MD Torres, Keisha MD, MPH, MBA Montalmant, Avra MD Laarakker, John H. MD Pang, Bella MD Avanessian, Elan MD Horesh, Peter MD Henderson, Rajveer S. MD, MPH Purohit, Scott MD Horn, Jess MD Ting. “The Effects of Intraoperative Methadone on Transgender and Gender-diverse Patients Receiving Vaginoplasty.” Oral Presentation.

ENDO | San Francisco, California | July 12-15, 2025 1.

Daniela Shill, MPH, Mbaye Farimata, Rachel Kasdin, Christopher Joseph Romero, MD, Ralph Fader, Neha Malhotra, Mabel Yau, MD. “SUN-130 Variation in GenderAffirming Care Initiation and Fertility Preservation Strategies Among Transgender Youth”. Oral Presentation.

Farimata Mbaye, Daniela Shill, MPH, Rachel Kasdin, Malhotra Neha, Christopher Joseph Romero, MD, Ralph Fader, Mabel Yau, MD. “SUN-129 Mental Health Complexities and Care Access for Transgender and Gender Diverse Youth: A Retrospective Cohort Study”. Oral Presentation.

Presentations 6th EPATH Conference | Hamburg, Germany | September 4-6, 2025 1.

Rajveer S. Purohit, Anne Yin, Camille Torres, Marta Bizic, Borko Stojanovic, Carlos Guerra, Marko Bencic, Francisco Andrade, Amro Harb, Miroslav Djordjevic. “Gender-Affirming Abdominal Phalloplasty: Techniques and Outcomes.”

Camille Torres, Borko Stojanovic, Marko Bencic, Amro Harb, Aubrey DiBello, Francisco Andrade, Michael Palese, Peter Wiklund, Miroslav L. Djordjevic, Rajveer Purohit. “Peritoneal Flap Versus Sigmoid Vaginoplasty for Re-Do GenderAffirming Vaginoplasty.”

Patrick Ho, Francisco Andrade, Camille Torres, Borko Stojanovic, Marko Bencic, Miroslav L. Djordjevic, Michael Palese, Rajveer Purohit. “Urinary Storage Symptoms After Gender-Affirming Vaginoplasty: Risk Factors and Prevention.”

Anne Yin, Camille Torres, Ömer Yazar, Michaela Sljivich, Kenan Celtik, Talia Stark, Miroslav Djordjevic, Rajveer Purohit, Borko Stojanovic, Marko Bencic, Giuseppe Di Taranto, Juan Tinajero, Miroslav L. Djordjevic. “Full Metoidioplasty With Vagina-Sparing: Technique and Outcomes.”

Camille Torres, Borko Stojanovic, Marko Bencic, Derek Chan, Peter Wiklund, Miroslav L. Djordjevic, Rajveer Purohit. “Robotic-Assisted Sigmoid Vaginoplasty for Feminizing Gender-Affirming Surgery: Feasibility and Outcomes.”

GURS Academic Congress | Minneapolis, Minnesota | September 25-27, 2025 1.

Anne Yin, Camille Torres, Ömer Yazar, Michaela Sljivich, Kenan Celtik, Talia Stark, Miroslav Djordjevic, Rajveer Purohit. “Full Metoidioplasty With Vagina-Sparing: Technique and Outcomes.

Sljivich M, Giordano L, Bizic M, Purohit RS. Bowel vaginoplasty. In: Selvaggi G, Djordjevic ML, eds. Gender Affirming Vaginoplasty. Elsevier; 2025.

Wolf‑Gould C, Safer JD. The biological underpinnings of gender identity. In: A History of Transgender Medicine in the United States. SUNY Press; 2025:474‑516. doi:10.1515/9798855801231‑016

Textbook Chapters 1.

Purohit RS, Torres C, Blaivas JG. Complications of female urethral reconstructive surgery. In: Goldman H, ed. Complications of Female Incontinence and Pelvic Reconstructive Surgery. 3rd ed. Springer; 2025. Coleman-Belin J, Torres C, Purohit RS. History of transgender surgery. In: Martins F, Kohler T, eds. Historical Perspective and Recent Advances in Reconstructive Urology. Springer; 2025.

Presentations USPATH | Santa Ana Pueblo, NM | September 26-30, 2025 1.

Sky Kihuwa-Mani, Chelsia Melendez, Subha Karim, Grace Travers, Bella Avanessian, John Pang, Rajveer Purohit, Jess Ting, Elan Horesh. “Early Dilation and Technique Matter: Reducing Introitus Dehiscence and Revisions After Vaginoplasty”. Oral Presentation. Elizabeth Cosby, Alyxandra Ramsay, Subha Karim, Peter Shamamian, Jacquelyn Roth, Janet Coleman-Belin, Uchechukwu Amakiri, Anya Wang, Derek Chen, Ivory Fu, Carol Wang, Keisha Montalmant, Avra Laarakker, John Pang, Ann Tran, Bella Avanessian, Elan Horesh, Jess Ting, Joshua Safer, Max Lichtenstein. “Serotonin-Selective Reuptake Inhibitor Use and Post-Operative Bleeding Risk in Individuals Undergoing GenderAffirming Vaginoplasty: A Retrospective Cohort Study”. Poster.

Pei-Ling Chang, MD; Joshua Safer, MD. “Investigating the Impact of Orchiectomy on Estradiol Dosing in Feminizing Gender-Affirming Hormone Therapy”. Poster.

Alyxandra Ramsay, M.S.Ed, Martha MacDonald, Subha Karim, and Alison Trebby, RN. “Voiding Issues and UTI Risk in Transgender Men Post-Masculinizing Surgery”. Oral Presentation.

Bernice Z. Yu, DO, Fliss Ehud MD, Ethan Fung, BS, Jacquelyn Roth, BA, Peter Shamanian, MD, Elan Horesh MD, Bella Avanessian MD, Jess Ting, MD. “Use of Tunica Vaginalis for Neovaginal Canal Lining in Penile Inversion Vaginoplasty”. Oral Presentation.

Ivory Fu and Yasmina Zogbhi. “Coagulation Concerns for Intersex Patients”. Oral Presentation.

Derek Chen, Jacquelyn Roth, Perri Vingan, Bernice Yu, Elan Horesh. “SSRI Use Does Not Impact Surgical Outcomes in Penile Inversion Vaginoplasty”. Oral Presentation

Subha Karim, Alexandra Ramsay, Ivory Fu, Max Lichtenstein, Yasmina Zogbhi, Elan Horesh, Bella Avanessian, John Henry Pang, Joshua Safer, Jess Ting. “The Impact of SSRI/SNRI Use on Postoperative Outcomes in Facial Feminization Surgery”. Oral Presentation.

Daniel Birkhead, Meghan Garrity, Christina Roberts. “Impact Of Anti-Transgender Legislation On Bullying And Mental Health Outcomes Among Transgender And Gender-Diverse Youth: An Interrupted Time Series Analysis”. Poster.

10. Madeline Deutsch, Natalie.Nokoff, Joshua D. Safer, Joanna Harper. “Developing A Strategic And Rational Evidence-Based Approach To Recommendations On Trans And Gender Expansive People Participating In Athletics”. Mini Symposia. 11.

Hinaleimoana Wong-Kalu, Joey Siosaia Joleen Mataele, Dani Moussouros. “Gender Diversity and Health in Polynesia.” Mini Symposia.

PSTM | New Orleans, Louisiana, | October 9-12, 2025 1.

Overview of Services Medical/Surgical Services

Behavioral Health

Adult Primary Care

Individual Counseling

Pediatric/Adolescent Care

Psychiatric Evaluations

Endocrinology including Gender Affirming Masculinizing Hormone Therapy Gender Affirming Feminizing Hormone Therapy

Pre- and Post-Surgical Psychotherapeutic Support

Gender Affirming Surgeries including Facial Feminization Surgeries Chest Reconstruction Surgeries Genital Reconstruction Surgeries Gynecological Procedures/Surgeries Other Urological Procedures Otolaryngologic Surgeries and Vocal Training

Support Services Social Work Trauma Care Pharmacy Services Telehealth Visits After-Hours Coverage MyChart

Ongoing Medication Management Pre-Surgical Evaluations Education for Individuals and Their Families Trauma-Informed Therapy

TRANS RIGHTS ARE HUMAN RIGHTS